Injectable antibodies in nanoparticles could replace hour-long infusions: A much faster, simpler treatment without an IV bag and an hour of getting needled. Just a single 2-ml shot of a solution containing solid nanoparticles packed with highly concentrated antibodies.

**Injectable antibodies in nanoparticles could replace hour-long infusions**

MIT engineer Patrick Doyle, senior author of the Advanced Materials paper “High-Concentration Antibody Formulation via Solvent-Based Dehydration,” is offering a significant breakthrough. Thanks to him and his colleagues Lucas Atia and Janet Teng, there’s a **much faster, simpler treatment without an IV bag and an hour of getting needled**, and a far more accessible treatment for people for whom simply getting to the hospital might be a major hassle or even an impossibility. **Just a single 2-ml shot of a solution containing solid nanoparticles packed with highly concentrated antibodies**.

That means injections with a standard 2-ml syringe could deliver 700 mg of antibodies in a single shot. For patients for whom hospital visits already mean losing paid-work hours of travel time and an hour for an infusion, this streamlined method offers a massive improvement in time, convenience, and comfort.

And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile medical practitioners could offer MIT microparticle emulsion as a no-fuss, no-muss solution – a literal solution of antibodies in a single injection.

For those interested, here’s the link to the peer reviewed journal article:

https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202516429